These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 7692086)
1. Distinctive effects of the carboxyl-terminal sequence of the insulin-like growth factor I receptor on its signaling functions. Liu D; Zong CS; Wang LH J Virol; 1993 Nov; 67(11):6835-40. PubMed ID: 7692086 [TBL] [Abstract][Full Text] [Related]
2. Modulating effects of the extracellular sequence of the human insulinlike growth factor I receptor on its transforming and tumorigenic potential. Liu D; Rutter WJ; Wang LH J Virol; 1993 Jan; 67(1):9-18. PubMed ID: 8380100 [TBL] [Abstract][Full Text] [Related]
3. Effect of dimerization on signal transduction and biological function of oncogenic Ros, insulin, and insulin-like growth factor I receptors. Chan JL; Lai M; Wang LH J Biol Chem; 1997 Jan; 272(1):146-53. PubMed ID: 8995240 [TBL] [Abstract][Full Text] [Related]
4. Effect of tyrosine mutations on the kinase activity and transforming potential of an oncogenic human insulin-like growth factor I receptor. Jiang Y; Chan JL; Zong CS; Wang LH J Biol Chem; 1996 Jan; 271(1):160-7. PubMed ID: 8550552 [TBL] [Abstract][Full Text] [Related]
5. Enhancement of transforming potential of human insulinlike growth factor 1 receptor by N-terminal truncation and fusion to avian sarcoma virus UR2 gag sequence. Liu D; Rutter WJ; Wang LH J Virol; 1992 Jan; 66(1):374-85. PubMed ID: 1309253 [TBL] [Abstract][Full Text] [Related]
6. Essential role of tyrosine residues 1131, 1135, and 1136 of the insulin-like growth factor-I (IGF-I) receptor in IGF-I action. Kato H; Faria TN; Stannard B; Roberts CT; LeRoith D Mol Endocrinol; 1994 Jan; 8(1):40-50. PubMed ID: 7512194 [TBL] [Abstract][Full Text] [Related]
7. Tyrosine residues in the C-terminal domain of the insulin-like growth factor-I receptor mediate mitogenic and tumorigenic signals. Esposito DL; Blakesley VA; Koval AP; Scrimgeour AG; LeRoith D Endocrinology; 1997 Jul; 138(7):2979-88. PubMed ID: 9202243 [TBL] [Abstract][Full Text] [Related]
8. Structure-function relationship of the insulin-like growth factor-I receptor tyrosine kinase. Grønborg M; Wulff BS; Rasmussen JS; Kjeldsen T; Gammeltoft S J Biol Chem; 1993 Nov; 268(31):23435-40. PubMed ID: 7693688 [TBL] [Abstract][Full Text] [Related]
9. Activation of the insulin-like growth factor type 1 receptor by deletion of amino acids 870-905. Li S; Zhang H; Hoff H; Sell C Exp Cell Res; 1998 Sep; 243(2):326-33. PubMed ID: 9743592 [TBL] [Abstract][Full Text] [Related]
10. Tyrosine kinase activity of a chimeric insulin-like-growth-factor-1 receptor containing the insulin receptor C-terminal domain. Comparison with the tyrosine kinase activities of the insulin and insulin-like-growth-factor-1 receptors using a cell-free system. Mothe I; Tartare S; Kowalski-Chauvel A; Kaliman P; Van Obberghen E; Ballotti R Eur J Biochem; 1995 Mar; 228(3):842-8. PubMed ID: 7737184 [TBL] [Abstract][Full Text] [Related]
11. Differential requirements of the MAP kinase and PI3 kinase signaling pathways in Src- versus insulin and IGF-1 receptors-induced growth and transformation of rat intestinal epithelial cells. Nguyen KT; Wang WJ; Chan JL; Wang LH Oncogene; 2000 Nov; 19(47):5385-97. PubMed ID: 11103940 [TBL] [Abstract][Full Text] [Related]
12. Oncogenic activation of v-kit involves deletion of a putative tyrosine-substrate interaction site. Herbst R; Munemitsu S; Ullrich A Oncogene; 1995 Jan; 10(2):369-79. PubMed ID: 7530827 [TBL] [Abstract][Full Text] [Related]
13. Molecular and biochemical bases for activation of the transforming potential of the proto-oncogene c-ros. Zong CS; Poon B; Chen J; Wang LH J Virol; 1993 Nov; 67(11):6453-62. PubMed ID: 8411348 [TBL] [Abstract][Full Text] [Related]
14. The carboxyl-terminal domain of insulin-like growth factor-I receptor interacts with the insulin receptor and activates its protein tyrosine kinase. Li S; Termini J; Hayward A; Siddle K; Zick Y; Koval A; LeRoith D; Fujita-Yamaguchi Y FEBS Lett; 1998 Jan; 421(1):45-9. PubMed ID: 9462837 [TBL] [Abstract][Full Text] [Related]
15. Insulin and insulin-like growth factor-I receptors similarly stimulate deoxyribonucleic acid synthesis despite differences in cellular protein tyrosine phosphorylation. Mastick CC; Kato H; Roberts CT; LeRoith D; Saltiel AR Endocrinology; 1994 Jul; 135(1):214-22. PubMed ID: 7516864 [TBL] [Abstract][Full Text] [Related]
16. Interaction of the molecular weight 85K regulatory subunit of the phosphatidylinositol 3-kinase with the insulin receptor and the insulin-like growth factor-1 (IGF- I) receptor: comparative study using the yeast two-hybrid system. Tartare-Deckert S; Murdaca J; Sawka-Verhelle D; Holt KH; Pessin JE; Van Obberghen E Endocrinology; 1996 Mar; 137(3):1019-24. PubMed ID: 8603569 [TBL] [Abstract][Full Text] [Related]
17. Dexamethasone enhances insulin-like growth factor-I effects on skeletal muscle cell proliferation. Role of specific intracellular signaling pathways. Giorgino F; Smith RJ J Clin Invest; 1995 Sep; 96(3):1473-83. PubMed ID: 7544807 [TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor induces phosphorylation of immunoreactive insulin receptor substrate and its association with phosphatidylinositol-3 kinase in human thymocytes. Kooijman R; Lauf JJ; Kappers AC; Rijkers GT J Exp Med; 1995 Aug; 182(2):593-7. PubMed ID: 7543144 [TBL] [Abstract][Full Text] [Related]
19. A conserved amino-terminal Shc domain binds to phosphotyrosine motifs in activated receptors and phosphopeptides. van der Geer P; Wiley S; Lai VK; Olivier JP; Gish GD; Stephens R; Kaplan D; Shoelson S; Pawson T Curr Biol; 1995 Apr; 5(4):404-12. PubMed ID: 7542991 [TBL] [Abstract][Full Text] [Related]
20. Association and phosphorylation-dependent dissociation of proteins in the insulin receptor complex. Zhang W; Johnson JD; Rutter WJ Proc Natl Acad Sci U S A; 1993 Dec; 90(23):11317-21. PubMed ID: 7504303 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]